BeStock  
Stocks › TARS

Tarsus Pharmaceuticals TARS

US equityMarket cap rank #2378
$74.46 +$1.46 (+1.99%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $74.46 0.00%
Open$73.22
Prev close$73.00
Day range$72.76 – $75.00
Volume939.6K
Market cap$3.48B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-69.6x
CheapRich

Near the bottom of its 5-year range · 2nd percentile, 5-year average -17.5x

Price / book10.0x
CheapRich

Near the top of its 5-year range · 96th percentile, 5-year average 5.0x

#4863 of 5315 stocks by PB (1 = cheapest)

P/E over five years

-88x-57x-25x7xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$65.15
Price vs. fair value+14.3%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 10.05 – 5.02 96% (pricier than usual) #4863 of 5315 (1 = cheapest)
PE -69.58 -32.94 -17.52 2% (cheaper than usual) –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$65.15
Economic moatNone
UncertaintyHigh

Discussion

No comments yet — be the first to weigh in on TARS.

Leave a comment

Scroll to Top